NCT00317980View on ClinicalTrials.gov

Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

December 31, 2008

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

Meglumine antimoniate

Meglumine antimoniate 5mg/kg/d for 20 days

DRUG

Meglumine antimoniate

Meglumine antimoniate 15 mg/kg/d for 20 days

Trial Locations (1)

70904-970

Núcleo de Medicina Tropical, University of Brasilia, Brasília

All Listed Sponsors
collaborator

Ministry of Health, Brazil

OTHER_GOV

lead

University of Brasilia

OTHER

NCT00317980 - Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis | Biotech Hunter | Biotech Hunter